The preclinical pharmacology of PRO1102, a novel exatecan-based HER2-directed antibody-drug conjugate with robust anti-tumor activityLei Wang,Haidong Liu,Xiao Shang,Tae H. Han,Baiteng ZhaoCANCER RESEARCH（2022）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
